A Prospective, Observational, Post-approval Registry of Inhibitor Patients Treated With Multiple or Single Doses of Recombinant Activated Factor VII

Seminars in Hematology

Volumn 45, Issue SUPPL. 1, 2008, Pages

  Chambost, Hervé ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANALGESIA; ARTICLE; DISEASE REGISTRY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; HEMOPHILIA; HEMOSTASIS; HUMAN; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTOR INHIBITORS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; EUROPE; FACTOR VIIA; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REGISTRIES;

EID: 44649202045     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.03.007     Document Type: Article

References (11)

1. Kenet G., Lubetsky A., Luboshitz J., and Martinowitz U. A new approach to treatment of bleeding episodes in young hemophilia patients: A single bolus megadose of recombinant activated factor VII (NovoSeven). J Thromb Haemost 1 (2003) 450-455
2. Kenet G. High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors. Semin Hematol 43 suppl 1 (2006) S108-S110
3. Key N.S., Aledort L.M., Beardsley D., Cooper H.A., Davignon G., Ewenstein B.M., et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 80 (1998) 912-918
4. Parameswaran R., Shapiro A.D., Gill J.C., and Kessler C.M. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: Analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia 11 (2005) 100-106
5. Santagostino E., Mancuso M.E., Rocino A., Mancuso G., Scaraggi F., and Mannucci P.M. A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. J Thromb Haemost 4 (2006) 367-371
6. Komvilaisak P., Connolly B., Naqvi A., and Blanchette V. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders. Haemophilia 12 suppl 6 (2006) 87-93
7. Carr Jr. M.E., Martin E.J., Kuhn J.G., and Seremetis S.V. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion. Thromb Haemost 89 (2003) 803-811
8. Proulle V., Hugel B., Guillet B., Trichet C., Rafowicz A., Lambert T., et al. Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles. Thromb Haemost 91 (2004) 873-878
9. He S., Ekman G.J., and Hedner U. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia. J Thromb Haemost 3 (2005) 272-279
10. Wolberg A.S., Allen G.A., Monroe D.M., Hedner U., Roberts H.R., and Hoffman M. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Br J Haematol 131 (2005) 645-655
11. Kavakli K., Makris M., Zulfikar B., Erhardtsen E., Abrams Z.S., Kenet G., et al. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial. Thromb Haemost 95 (2006) 600-605